EB
Eva Blem
About Eva Blem
Data last updated:
Eva Blem is an Additional Director at Xellia Pharmaceuticals Private Limited (since 2026). The company operates in Business Services. Xellia Pharmaceuticals Private Limited reported revenue of ₹28.32 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 12 Jan 2026 | ₹28.32 Cr (FY 2025) | Active |
Board colleagues of Eva Blem
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kasi Visweswara Venkata Satya Lakshmi Nagakishore Sripada | 11416360 | Xellia Pharmaceuticals Private Limited | Additional Director |
| Per Bork Eppers | 11469479 | Xellia Pharmaceuticals Private Limited | Additional Director |
| Soren Hostrup | 10724148 | Xellia Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Eva Blem
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eva Blem
Eva Blem currently holds 1 directorship: Xellia Pharmaceuticals Private Limited (Additional Director, since 12 Jan 2026, revenue ₹28.32 Cr (FY 2025)).
Eva Blem was first appointed on 12 Jan 2026 as Additional Director at Xellia Pharmaceuticals Private Limited.
The current boards of Eva Blem's companies include Kasi Visweswara Venkata Satya Lakshmi Nagakishore Sripada (Xellia Pharmaceuticals Private Limited), Per Bork Eppers (Xellia Pharmaceuticals Private Limited), Soren Hostrup (Xellia Pharmaceuticals Private Limited).